These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1326538)

  • 1. Characterization of the structure of a low Km, rolipram-sensitive cAMP phosphodiesterase. Mapping of the catalytic domain.
    Jin SL; Swinnen JV; Conti M
    J Biol Chem; 1992 Sep; 267(26):18929-39. PubMed ID: 1326538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation.
    Sette C; Conti M
    J Biol Chem; 1996 Jul; 271(28):16526-34. PubMed ID: 8663227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
    Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
    Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3).
    He R; Komas N; Ekholm D; Murata T; Taira M; Hockman S; Degerman E; Manganiello VC
    Cell Biochem Biophys; 1998; 29(1-2):89-111. PubMed ID: 9631240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties and hormonal regulation of two structurally related cAMP phosphodiesterases from the rat Sertoli cell.
    Swinnen JV; Tsikalas KE; Conti M
    J Biol Chem; 1991 Sep; 266(27):18370-7. PubMed ID: 1655746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of inhibitor binding sites of the cAMP-specific phosphodiesterase 4.
    Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
    Cell Signal; 2001 Apr; 13(4):287-97. PubMed ID: 11306246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial characterization of the active site human platelet cAMP phosphodiesterase, PDE3A, by site-directed mutagenesis.
    Cheung PP; Yu L; Zhang H; Colman RW
    Arch Biochem Biophys; 1998 Dec; 360(1):99-104. PubMed ID: 9826434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of two rat genes coding for closely related rolipram-sensitive cAMP phosphodiesterases. Multiple mRNA variants originate from alternative splicing and multiple start sites.
    Monaco L; Vicini E; Conti M
    J Biol Chem; 1994 Jan; 269(1):347-57. PubMed ID: 8276818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The short-term activation of a rolipram-sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation.
    Sette C; Iona S; Conti M
    J Biol Chem; 1994 Mar; 269(12):9245-52. PubMed ID: 8132662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and mutagenesis of the catalytic domain of cGMP-inhibited phosphodiesterase (PDE3) cloned from human platelets.
    Tang KM; Jang EK; Haslam RJ
    Biochem J; 1997 Apr; 323 ( Pt 1)(Pt 1):217-24. PubMed ID: 9173884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cDNA of a human lymphocyte cyclic-AMP phosphodiesterase (PDE IV) reveals a multigene family.
    Obernolte R; Bhakta S; Alvarez R; Bach C; Zuppan P; Mulkins M; Jarnagin K; Shelton ER
    Gene; 1993 Jul; 129(2):239-47. PubMed ID: 8392015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast.
    Torphy TJ; Stadel JM; Burman M; Cieslinski LB; McLaughlin MM; White JR; Livi GP
    J Biol Chem; 1992 Jan; 267(3):1798-804. PubMed ID: 1309798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.
    Jacobitz S; McLaughlin MM; Livi GP; Burman M; Torphy TJ
    Mol Pharmacol; 1996 Oct; 50(4):891-9. PubMed ID: 8863835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A low-Km, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain. Cloning and expression of cDNA, biochemical characterization of recombinant protein, and tissue distribution of mRNA.
    McLaughlin MM; Cieslinski LB; Burman M; Torphy TJ; Livi GP
    J Biol Chem; 1993 Mar; 268(9):6470-6. PubMed ID: 8384210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification, characterization and analysis of rolipram inhibition of a human type-IVA cyclic AMP-specific phosphodiesterase expressed in yeast.
    Wilson M; Sullivan M; Brown N; Houslay MD
    Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):407-15. PubMed ID: 7528009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human phosphodiesterase 4A: characterization of full-length and truncated enzymes expressed in COS cells.
    Owens RJ; Catterall C; Batty D; Jappy J; Russell A; Smith B; O'Connell J; Perry MJ
    Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):53-60. PubMed ID: 9337850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association with the SRC family tyrosyl kinase LYN triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B. Consequences for rolipram inhibition.
    McPhee I; Yarwood SJ; Scotland G; Huston E; Beard MB; Ross AH; Houslay ES; Houslay MD
    J Biol Chem; 1999 Apr; 274(17):11796-810. PubMed ID: 10206997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram.
    Shakur Y; Pryde JG; Houslay MD
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):677-86. PubMed ID: 7686364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase.
    Livi GP; Kmetz P; McHale MM; Cieslinski LB; Sathe GM; Taylor DP; Davis RL; Torphy TJ; Balcarek JM
    Mol Cell Biol; 1990 Jun; 10(6):2678-86. PubMed ID: 2160582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae.
    Michaeli T; Bloom TJ; Martins T; Loughney K; Ferguson K; Riggs M; Rodgers L; Beavo JA; Wigler M
    J Biol Chem; 1993 Jun; 268(17):12925-32. PubMed ID: 8389765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.